Published 2011
| Version v1
Publication
MEK inhibitor as a single agent and in combination with everolimus or sorafenib in a panel of colorectal cancer cell lines: implication for multitargeted approach
Additional details
- URL
- http://hdl.handle.net/11567/999482
- URN
- urn:oai:iris.unige.it:11567/999482
- Origin repository
- UNIGE